PATENT CLAIM ANALYSIS

Application Number: 15564969
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-03
Patent Classification: ["424", "135100"]

Abstract:
The present invention provides, among other things, methods and compositions for treating chronic lung disorders, in particular, bronchopulmonary dysplasia (BPD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to BPD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of BPD is reduced in intensity, severity, or frequency, or has delayed onset.

Claim (Index 5):
The method of  claim 1  or  4 , wherein the anti-Flt-1 antibody or antigen binding fragment thereof has binding affinity to human Flt-1 greater than 10 \u221210 M in a surface plasmon resonance binding assay.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14763881', '12069757', '14605649', '11277121', '12220245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6950165650120915
- 35 USC 102 Novelty (BERT): 0.5452154196781057
- Combined Prediction Score: 0.680036450478693
- Mean Citation Score: 284.565086
- Max Citation Score: 380.26782
- Similarity Product: 265.00375180478807

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test